EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

A prospective observational study of plasma concentrations and safety of combined intravenous lidocaine and epidural ropivacaine in laparotomy surgery

Ottilie Trocheris-Fumery iD, Alexandre Pruvot, Paul Tarpin iD, Sophie Collette, Sandra Bodeau, Momar Diouf, Jean-Marc Régimbeau, Hervé Dupont, Stéphane Bar, Youssef Bennis, Osama Abou-Arab

PLOS One · 06.03.2026 · 21 (3) · e0344277

DOI: 10.1371/journal.pone.0344277 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, online erschienen am 06.03.2026. Verfasst von Ottilie Trocheris-Fumery und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care Medicine, Amiens Picardy University Hospital, Amiens, France. Hauptthemen laut MEDLINE: Ropivacaine, Lidocaine, Laparotomy, Anesthetics, Local. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intravenous lidocaine (IVL), an alternative to epidural analgesia (EA) for laparotomies, has demonstrated anti-inflammatory and anti-hyperalgesic effects. However, its combination with EA raises concerns about systemic toxicity. This study aimed to assess the safety of this combination in patients undergoing laparotomy. We conducted a prospective observational study at Amiens University Hospital in France, involving adult patients scheduled for laparotomies. Intravenous lidocaine was administered at induction as a 1.5 mg/kg bolus (ideal body weight), followed by a continuous infusion of 2 mg/kg/h maintained until the end of surgery. An epidural catheter was inserted before surgery, prior to induction of general anesthesia, no local anesthetic was administered intraoperatively. Epidural analgesia was initiated at the end of surgery with a 5 mg bolus of ropivacaine, followed by a continuous infusion. The primary outcome was the occurrence of lidocaine and ropivacaine plasma concentrations outside established safety ranges. Lidocaine plasma concentrations were measured 30 minutes after bolus (LP1), at the end of surgery (LP2), and two hours after discontinuation of the infusion (LP3). Ropivacaine concentrations were measured two hours (RP1) and 24 hours after initiation of epidural infusion (RP2). The secondary endpoint the assessment of cardiac and neurological toxicity within 48 hours post-surgery. Fifty patients were included from March 2022 to March 2024. One patient exceeded the lidocaine threshold (LP2), and another exceeded the ropivacaine threshold (RP2). LP1 was 1.8 [1.5–2.4] µg/ml, LP2 was 2.1 [1.6–2.4] µg/ml, and LP3 was 1.2 [0.8–1.7] µg/ml. Ropivacaine plasma concentration was 126 [87–211] µg/L at RP1, and 785 [524–1318] µg/L at RP2. No cardiac or neurological adverse events were observed. The combination of EA and IVL appeared to be safe for major abdominal surgery. Clinical trials Number NCT05368753. EudraCT Number: 2021-005508-37.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RopivacaineLidocaineLaparotomyAnesthetics, LocalAnalgesia, EpiduralHumansProspective StudiesFemaleMaleMiddle AgedAgedAdultAmides

Substanzen

RopivacaineLidocaineAnesthetics, LocalAmides

Autor:innen und Institutionen

  • Department of Anesthesiology and Critical Care Medicine, Amiens Picardy University Hospital, Amiens, France.
  • Centre for pain assessment and treatment, Amiens Picardy University Hospital, Amiens, France.
  • Department of Clinical Pharmacology, Amiens Medical Centre, Amiens, France.
  • Clinical research division, Amiens Hospital University, Amiens, France.
  • Department of Digestive Surgery, Amiens Picardy University Hospital, 1, rondpoint du Pr-Cabrol, Simplifying Care for Complex Patients, UR-UPJV SSPC, Clinical Research Unit, University of Picardie Jules-Verne, Amiens, Fr…

ORCID-Profile: Ottilie Trocheris-Fumery, Paul Tarpin

Zitieren

APA

Trocheris-Fumery, O., Pruvot, A., Tarpin, P., Collette, S., Bodeau, S., Diouf, M., Régimbeau, J. M., Dupont, H., Bar, S., Bennis, Y., & Abou-Arab, O. (2026). A prospective observational study of plasma concentrations and safety of combined intravenous lidocaine and epidural ropivacaine in laparotomy surgery. PLOS One, 21(3), e0344277. https://doi.org/10.1371/journal.pone.0344277

Vancouver

Trocheris-Fumery O, Pruvot A, Tarpin P, Collette S, Bodeau S, Diouf M, et al. A prospective observational study of plasma concentrations and safety of combined intravenous lidocaine and epidural ropivacaine in laparotomy surgery. PLOS One. 2026;21(3):e0344277. doi:10.1371/journal.pone.0344277

BibTeX
@article{TrocherisFumery2026,
  author = {Trocheris-Fumery, Ottilie and Pruvot, Alexandre and Tarpin, Paul and Collette, Sophie and Bodeau, Sandra and Diouf, Momar and Régimbeau, Jean-Marc and Dupont, Hervé and Bar, Stéphane and Bennis, Youssef and Abou-Arab, Osama},
  title = {A prospective observational study of plasma concentrations and safety of combined intravenous lidocaine and epidural ropivacaine in laparotomy surgery},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0344277},
  doi = {10.1371/journal.pone.0344277}
}
Kostenlos starten →